Pyxis Oncology issues 49,310,352 common stock warrants in $110 million offering
Bitget2026/09/30 05:11- Pyxis Oncology priced a public offering with 1,883,121 pre-funded warrants issued alongside common warrants for 49,310,352 shares.
- Common warrants carry a $3.50 exercise price. They become exercisable only after stockholder approval of an authorized-share increase.
- Common warrants expire at the earlier of five years from the charter amendment’s effective date or 30 days after overall survival data disclosure.
- Full exercise of the common warrants and pre-funded warrants would raise an additional USD 172.6 million in gross proceeds.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
Mortgage rates return to 7%, pending home sales in the US fall to nearly a twelve-year low
According to Freddie Mac data, the 30-year fixed mortgage rate has risen to 7.4%, the highest level in nearly three years. Data from real estate brokerage Redfin shows that the volume of existing home pending sales in September fell 4% month-on-month, marking the largest single-month drop in over three years and hitting the lowest level since 2014. Nearly one-fifth of sellers have reduced prices, and the home purchase contract cancellation rate has reached a record high of 14.5%. Inventory levels have risen to the highest since March 2020, but high financing costs continue to constrain transactions.
Mueller Water Products names Michael Morgan CFO, succeeding Melissa Rasmussen
GLD ETF Falls 0.6%
Crypto prices
More
